Relate
insulin glargine [rDNA origin]; Lantus |
Blood Sugar; Diabetes Mellitus; Non-Insulin Dependent Diabetes Mellitus; Type II Diabetes | |
|
Lantus is used to treat adults and children (age 6 and older) with type 1 diabetes or adult patients with type 2 diabetes who require long-acting insulin to control high blood sugar.
|
Diabetes is a disorder of metabolism--the way our bodies use digested food for growth and energy. Most of the food we eat is broken down into glucose, the form of sugar in the blood. Glucose is the main source of fuel for the body. After digestion, glucose passes into the bloodstream, where it is used by cells for growth and energy. For glucose to get into cells, insulin must be present. Insulin is a hormone produced by the pancreas, a large gland behind the stomach. When we eat, the pancr...
|
Insulin glargine as related to Diabetes
- LANTUS® (insulin glargine [rDNA origin] injection) Diabetes Therapy
Learn about LANTUS® the only 24-hour insulin approved exclusively for use once a day. Find out how LANTUS, as part of a diabetes treatment plan, can help patients with type 1 ...
- Insulin glargine - Wikipedia, the free encyclopedia
Insulin glargine , marketed by Sanofi-Aventis under the name Lantus , is a long-acting basal insulin analogue , usually given once or twice daily to help control the blood sugar level of those with diabetes . Its theoretical advantage is that it has a duration of action up to 24 hours, with a "less peaked" profile than NPH.
- Insulin glargine - Diabetes Wiki - Personal stories, information, and ...
Insulin glargine (brand name Lantus[1]) is a long-acting insulin manufactured by Sanofi Aventis. It is dosed once or twice a day in two equal doses, and is available in a ... ...
- Insulin glargine (Lantus) - Diabetes UK
Insulin glargine (Lantus) Information about Insulin glargine. What is insulin glargine? Insulin glargine (trade name Lantus) is a form of longer acting insulin.
- Diabetes Research Summary - Insulin and Low Blood Glucose - American ...
Reduced hypoglycemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes , by J. Rosenstock and colleagues. Diabetes ...
- Insulin - Wikipedia, the free encyclopedia
... at Library and Archives Canada; McKeage K, Goa KL. (2001) Insulin glargine: a review of its therapeutic use as a long-acting agent for the management of type 1 and 2 diabetes mellitus
- Diabetes Monitor - Lantus (insulin glargine)
Lantus® (insulin glargine) is a synthetic long-lasting insulin product. It is now on the market in many countries. Lantus® (insulin glargine)
- Insulin Glargine
return to index Guidelines for Using Insulin Glargine (Lantus®) for Hospitalized Patients with Diabetes Mellitus (DM) 1. Indications for Insulin Glargine in Type 1 Diabetes:
- children with DIABETES - Lantus (Insulin Glargine)
Children with Diabetes is the online community for parents, kids, adults, and families living with type 1 diabetes. ... Overview. Lantus® (insulin glargine) is a very long acting ...
- MedlinePlus Drug Information: Insulin Glargine (rDNA origin ...
Insulin Glargine (rDNA origin) Injection ... Why is this medication prescribed? Return to top. Insulin glargine is used to treat type 1 diabetes (condition in which the body ...

Not Signed In -


